About: http://data.cimple.eu/news-article/87a5bebfa46acbcb01b7525b5848678cfe92b9589d87d141542f8281

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/87a5bebfa46acbcb01b7525b5848678cfe92b9589d87d141542f8281 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The United States is expected to authorize the Pfizer-BioNTech Covid-19 vaccine for children age 12 and up by early next week, US media reported Monday. Pfizer has applied for emergency use authorization for its Covid vaccine for children and teenagers between ages 12 and 15, according to CNN, citing a government official. "The FDA will have to amend the emergency use authorization for the vaccine, but the process should be straightforward," CNN reported. The US Food and Drug Administration is expected to grant that approval by early next week. After the FDA decision, the Centers for Disease Control and Prevention advisory committee will meet to recommend how the vaccine should be used. A spokeswoman for the FDA declined to give details on the approval timeline, telling The Washington Post: "We are working to review this request as quickly and transparently as possible." The Pfizer vaccine is currently authorized for people 16 and older in the United States. The US pharmaceutical giant said in late March it had submitted data from a clinical trial of 2,260 12- to 15-year-olds that showed the vaccine was highly effective and well-tolerated. Further testing on younger children is ongoing. Moderna is conducting trials of its vaccine in teens, with results expected in the summer, as well as in younger children. Johnson & Johnson is also planning pediatric trials for its vaccine. Expanding vaccine authorization to include adolescents could open up the US mass vaccination program to millions more people. The national vaccination rate peaked around April 11, according to official data, and although 55 percent of US adults now have had one or more doses, there's still a long way to go to achieve population immunity against Covid. The people most eager to get their shots have, for the most part, already rolled up their sleeves and done so. But vaccine hesitancy remains a major obstacle: a large percentage of US adults don't plan to get the shot and could potentially refuse to get their children vaccinated. Among Republican voters, 29 percent say they will never take the vaccine, compared to five percent of Democrats and nine percent of independents, according to a recent survey by the Kaiser Family Foundation. to/caw
schema:headline	US to authorize Pfizer vaccine for age 12 and up: report
schema:mentions	Pediatrics Legal immunity Clinical trial The Washington Post Johnson & Johnson Vaccine hesitancy History of the United States Republican Party Food and Drug Administration CNN Pfizer Coronavirus disease Vaccine United States Coronavirus disease 2019 Kaiser Family Foundation Canadian Auto Workers
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	77 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software